Practical approach to scoring HER2 immunohistochemistry in breast cancer in the wake of updated guidelines

Histopathology. 2024 Mar;84(4):715-718. doi: 10.1111/his.15117. Epub 2023 Dec 12.

Authors

Puay Hoon Tan¹, Gudi Mihir², Natthawadee Laokulrath^{2

3}, Emad Rakha⁴

Affiliations

¹ Luma Medical Centre, Royal Square Medical Centre, Singapore, Singapore.
² Department of Pathology, KK Women's and Children's Hospital, Singapore, Singapore.
³ Department of Pathology, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
⁴ Cellular Pathology Department, School of Medicine, University of Nottingham, Nottingham, UK.

PMID: 38087653
DOI: 10.1111/his.15117

No abstract available

Publication types

Letter

MeSH terms

Biomarkers, Tumor
Breast Neoplasms*
Female
Humans
Immunohistochemistry
Receptor, ErbB-2

Substances

Receptor, ErbB-2
Biomarkers, Tumor